Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial-Reference-Cited by-同舟云学术

Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial

Published:2009-03-31 Issue:4 Volume:2 Page:310-321
ISSN:1940-6207
Container-title:Cancer Prevention Research
language:en
Short-container-title:Cancer Prev Res

Author:

Bertagnolli Monica M.,Eagle Craig J.,Zauber Ann G.,Redston Mark,Breazna Aurora,Kim KyungMann,Tang Jie,Rosenstein Rebecca B.,Umar Asad,Bagheri Donya,Collins Neal T.,Burn John,Chung Daniel C.,Dewar Thomas,Foley T. Raymond,Hoffman Neville,Macrae Finlay,Pruitt Ronald E.,Saltzman John R.,Salzberg Bruce,Sylwestrowicz Thomas,Hawk Ernest T.,

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EP2/EP4 targeting prevents tumor-derived PGE2-mediated immunosuppression in cDC2s;Journal of Leukocyte Biology;2024-07-23

2. A Contemporary Review on the Critical Role of Nonsteroidal Anti-inflammatory Agents in Colorectal Cancer Therapy;Anti-Cancer Agents in Medicinal Chemistry;2024-05

3. EP2 and EP4 blockade prevents tumor-induced suppressive features in human monocytic myeloid-derived suppressor cells;Frontiers in Immunology;2024-01-26

4. Neutralizing tumor-related inflammation and reprogramming of cancer-associated fibroblasts by Curcumin in breast cancer therapy;Scientific Reports;2023-11-26

5. Colorectal polyp outcomes after participation in the seAFOod polyp prevention trial: Evidence of rebound elevated colorectal polyp risk after short‐term aspirin use;Alimentary Pharmacology & Therapeutics;2023-07-30